ClinicalTrials.govpublic full text
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC
liver cancer, hepatocellular carcinoma, resistant cancer, aurora a kinase inhibitor, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 981014
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.